Shackelford Pharma congratulates O’Neill D’Cruz, a member of Shackelford’s clinical development team, and our Scientific Advisory Board Members Emilio Perucca and Jeffrey Buchhalter, co-authors of the article “EEG Parameters as Endpoints in Epilepsy Clinical Trials- An Expert Panel Opinion Paper” published this month in Epilepsy Research.
Link to the article: https://authors.elsevier.com/c/1fxZ33HDXae9E4